Methylphenidate Hydrochloride 13811-0711-30
- Manufacturer
- Trigen Laboratories, Llc
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- June 23, 2022
- Listing Expires
- December 31, 2026
- Application
- NDA216117
Active Ingredients
| Ingredient | Strength |
|---|---|
| Methylphenidate Hydrochloride | 45 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Selected Package
13811-0711-30Selected30 TABLET, EXTENDED RELEASE in 1 BOTTLE (13811-711-30)